Company / Working Capital per Share
Xenetic Biosciences, Inc. Working Capital per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital per Share
$4.59
FY2025
5-year range
$0.94 / $5.79
FY2021-FY2025
Trend
+24.3%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Working Capital per Share has fluctuated over the past 10 years, ranging from $-0.05 in FY2018 to $5.79 in FY2023.
Based on SEC 10-K filings.
4.59 in FY2025 with a 5-year CAGR of +19.5%.
Declined from $5.79 to $4.59 over the past 2 years.
Working Capital per Share over time
Growth rates
- 3-Year CAGR
- +69.9%
- 5-Year CAGR
- +19.5%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, working capital per share increased 24.3% year-over-year.
- Peak working capital per share was recorded in FY2023.
- Lowest working capital per share in the period was in FY2018.
Company context
Key Data Points
- Altman Z-Score 0.41 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working Capital per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $4.59 | +24.3% |
| FY2024 | $3.70 | -36.1% |
| FY2023 | $5.79 | +518.3% |
| FY2022 | $0.94 | -52.7% |
| FY2021 | $1.98 | +5.0% |
| FY2020 | $1.88 | +18.2% |
| FY2019 | $1.60 | +3526.5% |
| FY2018 | -$0.05 | -105.4% |
| FY2017 | $0.86 | -39.1% |
| FY2016 | $1.41 | +9626.2% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026